N-Methyl-4-(4-(3-(3-(trifluoromethyl)phenyl)ureido)phenoxy)picolinamide

97%

Reagent Code: #215746
fingerprint
CAS Number 1285533-84-7

science Other reagents with same CAS 1285533-84-7

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 430.38 g/mol
Formula C₂₁H₁₇F₃N₄O₃
badge Registry Numbers
MDL Number MFCD29041974
thermostat Physical Properties
Melting Point 187.6 °C
Boiling Point 498.1±45.0 °C(Predicted)
inventory_2 Storage & Handling
Density 1.399±0.06 g/cm3(Predicted)
Storage Room temperature, seal, dry

description Product Description

Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 1 (JAK1), showing potential for treating autoimmune and inflammatory diseases such as rheumatoid arthritis and psoriasis. Its structure enables high selectivity for JAK1 over other JAK family members, which may reduce side effects commonly associated with broader JAK inhibition. Currently investigated in preclinical and clinical studies for optimizing therapeutic efficacy and safety in chronic inflammatory conditions.

Available Sizes & Pricing

Size Availability Unit Price Quantity
100mg
10-20 days ฿16,000.00
N-Methyl-4-(4-(3-(3-(trifluoromethyl)phenyl)ureido)phenoxy)picolinamide
No image available

Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 1 (JAK1), showing potential for treating autoimmune and inflammatory diseases such as rheumatoid arthritis and psoriasis. Its structure enables high selectivity for JAK1 over other JAK family members, which may reduce side effects commonly associated with broader JAK inhibition. Currently investigated in preclinical and clinical studies for optimizing therapeutic efficacy and safety in chronic inflammatory conditions.

Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 1 (JAK1), showing potential for treating autoimmune and inflammatory diseases such as rheumatoid arthritis and psoriasis. Its structure enables high selectivity for JAK1 over other JAK family members, which may reduce side effects commonly associated with broader JAK inhibition. Currently investigated in preclinical and clinical studies for optimizing therapeutic efficacy and safety in chronic inflammatory conditions.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...